Genomic surveillance and meningococcal group B vaccine coverage estimates after introduction of the vaccine into the national immunisation programme in the UK
Sign Up to like & getrecommendations! Published in 2017 at "The Lancet"
DOI: 10.1016/s0140-6736(17)30481-6
Abstract: Abstract Background In September, 2015, the meningococcal group B vaccine (Bexsero, GlaxoSmithKline) was introduced into the UK childhood immunisation schedule. Prelicensure coverage estimates used Meningococcal Antigen Typing System (MATS) to determine phenotype and function of… read more here.
Keywords: coverage estimates; meningococcal group; family; group vaccine ... See more keywords
Immunogenicity and safety of meningococcal group A, C, W and Y tetanus toxoid conjugate vaccine: review of clinical and real-world evidence.
Sign Up to like & getrecommendations! Published in 2019 at "Future microbiology"
DOI: 10.2217/fmb-2018-0343
Abstract: Protection by meningococcal group A, C, W and Y (MenACWY) vaccines against four meningococcal disease-causing serogroups is increasingly important because of changing epidemiologic patterns of meningococcal disease, including recent meningococcal serogroup W outbreaks/disease clusters. The… read more here.
Keywords: vaccine; meningococcal group; disease; tetanus toxoid ... See more keywords